Wed, March 6, 2024
Tue, March 5, 2024
Mon, March 4, 2024
Fri, March 1, 2024

Nathan Rich Maintained (AMRX) at Strong Buy with Increased Target to $6.25 on, Mar 4th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-6-25-on-mar-4th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Increased Target from $5.5 to $6.25 on, Mar 4th, 2024.

Nathan has made no other calls on AMRX in the last 4 months.



There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with Nathan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Nathan


  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $8 on, Monday, January 29th, 2024
  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $7 on, Wednesday, November 8th, 2023

Publication Contributing Sources